Author:
Li Guangsheng,Ma Ningyi,Wang Weiwei,Chen Jian Chen,Mao Jingfang,Jiang Guoliang Jiang,wu kailiang
Reference35 articles.
1. Cancer statistics, 2022;R L Siegel;CA Cancer J Clin,2022
2. Lung Cancer 2020: Epidemiology, Etiology, and Prevention;B C Bade;Clin Chest Med. Mar,2020
3. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer;D R Spigel;J Clin Oncol,2022
4. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study;R Hui;Lancet Oncol. Dec,2019